Sort
51,570 grants matching “autoimmune disease”
Define the role of dendritic cells in HTLV-1 associated neuroinflammatory disease
$389,900Pooja Jain · Drexel University · R01 · FY2009 · AI
Understanding the role of anti-apolipoprotein A-I antibodies in atherosclerotic cardiovascular disease
$389,899Vincent Joseph Venditto · University Of Kentucky · R56 · FY2019 · HL
Longitudinal Study of Immune Mediated Disorders After Allogeneic HCT
$389,898Stephanie J Lee · Fred Hutchinson Cancer Research Center · U54 · FY2011 · CA
Autoreactive CD4 T cells in healthy mice
$389,896Leszek Ignatowicz · Georgia State University · R01 · FY2021 · AI
Mechanistically based therapeutic strategies in murine primary biliary cholangitis
$389,889Merrill E Gershwin · University Of California At Davis · R01 · FY2023 · DK
Inflammasome-gasdermin axis in bullous pemphigoid
$389,854Zhi Liu · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AR
The Role of IL-II in the development of autoimmune response in multiple sclerosis
$389,850Silva Markovic-Plese · Thomas Jefferson University · R01 · FY2020 · AI
The Role of IL-II in the development of autoimmune response in multiple sclerosis
$389,850Silva Markovic-Plese · Thomas Jefferson University · R01 · FY2019 · AI
Role of the ADAR1-mediated RNA editing â RNA sensing axis in sterile inflammation
$389,838Qingde Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
Role of the ADAR1-mediated RNA editing â RNA sensing axis in sterile inflammation
$389,838Qingde Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
Role of the ADAR1-mediated RNA editing â RNA sensing axis in sterile inflammation
$389,838Qingde Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
FUNCTIONS OF E2A IN B LYMPHOCYTE DEVELOPMENT
$389,830Duke University · R01 · FY2003 · CA
Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
$389,802Raif Salim Geha · Boston Children'S Hospital · R01 · FY2020 · AI
ApoB-specific CD4 T cells in mouse and human atherosclerosis
$389,777Klaus F. Ley · La Jolla Institute For Immunology · P01 · FY2021 · HL
Structural and Biochemical Studies of Blood Coagulation Factor VIII to Overcome the Immune Response
$389,770Paul Clinton Spiegel · Western Washington University · R15 · FY2021 · HL
The Role of IGRP in the Pathogenesis of Type 1 Diabetes
$389,760Richard M O'Brien · Vanderbilt University · R01 · FY2008 · DK
Prevention of Retinal Degeneration by Crystallins in Experimental Uveitis
$389,750Narsing A Rao · Doheny Eye Institute · R01 · FY2009 · EY
Prevention of Retinal Degeneration by Crystallins in Experimental Uveitis
$389,750Narsing A Rao · Doheny Eye Institute · R01 · FY2008 · EY
Nodal Points in Marfan Syndrome Progression
$389,746Daniel B Rifkin · Icahn School Of Medicine At Mount Sinai · P01 · FY2012 · AR
Phase II Trial of methotrexate in myasthenia gravis FDA IND#:101,306 01/06/2008
$389,739Richard J. Barohn · University Of Kansas Medical Center · R01 · FY2011 · FD
Arginase positive monocyte mediated RGC neuroprotection after traumatic optic neuropathy
$389,739Andrew Robert Sas · Ohio State University · R01 · FY2025 · EY
Targeted Abrogation of the FXII-uPAR-pAkt2 Axis in Neutrophils for Treatment of Chronic Wounds
$389,739Evi X. Stavrou · Case Western Reserve University · R01 · FY2019 · HL
Contribution of β-Cell- & Immune Cell-Derived Lipids to β-Cell Death and Diabetes
$389,738Sasanka Ramanadham · University Of Alabama At Birmingham · R01 · FY2016 · DK
Contribution of β-Cell- & Immune Cell-Derived Lipids to β-Cell Death and Diabetes
$389,738Sasanka Ramanadham · University Of Alabama At Birmingham · R01 · FY2017 · DK
Spontaneous tubulointerstital nephritis in kdkd mice
$389,727David L Gasser · University Of Pennsylvania · R01 · FY2010 · DK